Research Topics
| Hartmut LodeSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free intervalH Lode
HELIOS Klinikum Emil von Behring, Zum Heckeshorn 33, D 14109 Berlin, Germany
Eur Respir J 24:947-53. 2004..In summary, levofloxacin was associated with a significantly higher bacteriological eradication rate but similar exacerbation-free interval in patients with chronic obstructive pulmonary disease exacerbation compared to clarithromycin...
Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or olderH Lode
Research Centre for Medical Studies, Institute of Clinical Pharmacology, Charite Universitatsmedizin Berlin, Hohenzollerndamm 2, Berlin, Germany
Vaccine 29:4940-6. 2011..Local reactions for the 4 × dose, but not the 2 × dose, were statistically significantly higher than for the 1 × dose. No treatment-related serious adverse events occurred...
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumoniaH Lode
Department of Chest and Infectious Diseases, Hospital Heckeshorn, affil Freie Universität Berlin, Berlin, Germany
Clin Microbiol Infect 10:512-20. 2004..Overall, this study showed that gatifloxacin was equivalent clinically to a standard course of co-amoxiclav in patients with community-acquired pneumonia, and that gatifloxacin was safe and well-tolerated...
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumoniaH Lode
Department of Chest and Infectious Diseases, Hospital Heckeshorn, affil Freie Universität Berlin, Berlin, Germany
Clin Microbiol Infect 10:403-8. 2004..Oral gatifloxacin 400 mg once-daily appeared to be a safe and effective alternative to clarithromycin in the treatment of community-acquired pneumonia...
Recent developments in antibiotic treatmentAndres De Roux
Department for Immunology and Infectious Diseases Pneumologie I, City Hospital Heckeshorn, Zentralklinik Emil von Behring, Affil Free University Berlin, Zum Heckeshorn 33, 14109 Berlin, Germany
Infect Dis Clin North Am 17:739-51. 2003..No antibiotic, regardless of its potency, can free the clinician from keeping the difficult balance between individual undertreatment and general overtreatment...
Gemifloxacin for community-acquired pneumoniaHartmut M Lode
RCMS, Hohenzollerndamm 2, Ecke Bundesallee, D 10717 Berlin Wilmersdorf, Germany
Expert Opin Investig Drugs 17:779-86. 2008..Gemifloxacin is one of the newest members of this class of antibiotics and has performed favourably in this indication...
[Problems of pharmacotherapy of infections in the aged]A Kuhnke
Abteilung für Lungen und Infektionskrankheiten, Zentralklinik Emil von Behring, Akademisches Lehrkrankenhaus, Freien Universitat Berlin
Internist (Berl) 44:986-94. 2003..Especially the newer antibiotics Ertapenem, Linezolid, Quinupristin/Dalfopristin and Telithromycin are discussed in detail...
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumoniaH Lode
Zentralklinik Emil von Behring, Lungenklinik Heckeshorn, Berlin 10115, Germany
Respir Med 97:1134-42. 2003..IV/PO moxifloxacin was evaluated in the treatment of hospitalized patients with severe community-acquired pneumonia (CAP)...
Role of newer fluoroquinolones in lower respiratory tract infectionsH Lode
Department of Chest and Infectious Diseases, Chest Hospital Heckershorn, Central Clinic Emil von Behring, Zum Heckeshorn 33, 14109 Berlin, Germany
J Antimicrob Chemother 50:151-4. 2002
Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?H Lode
Department of Chest and Infectious Diseases, Helios Klinikum E v Behring, Teaching Hospital Charité Berlin, Berlin, Germany
Clin Microbiol Infect 11:778-87. 2005..The development of novel and effective alternative agents, such as tigecycline, is therefore important...
Vasculitis and infection: effects of immunosuppressive therapyH M Lode
Department of Chest and Infectious Diseases, Helios Klinikum Emil von Behring affil Charité Universitätsmedizin, Berlin, Germany
Clin Nephrol 64:475-9. 2005..The contribution of infections to the mortality of vasculitis patients is important and should induce early and careful control of these events...
[Management of community-acquired pneumonia in the physician's office]H M Lode
HELIOS Klinikum Emil von Behring, Department Lungenklinik Heckeshorn
MMW Fortschr Med 148:32-5. 2006....
Moxifloxacin: update and perspectives after 8 years of usageHartmut M Lode
RCMS Institute for Clinical Pharmacology, , Hohenzollerndamm 2, D10717 Berlin, Germany
Expert Rev Respir Med 2:443-53. 2008..The most recent studies covering these clinical indications are discussed...
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infectionsHartmut Lode
City Hospital Berlin Zehlendorf, Free University of Berlin, Berlin, Germany
Am J Med 123:S26-38. 2010....
Clinical impact of antibiotic-resistant Gram-positive pathogensH M Lode
Research Centre for Medical Studies, Affiliated Institute for Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany
Clin Microbiol Infect 15:212-7. 2009..This review addresses the impact of antibiotic-resistant Gram-positive pathogens on clinical outcomes...
Rational antibiotic therapy and the position of ampicillin/sulbactamHartmut M Lode
Research Centre for Medical Studies, Institute of Clinical Pharmacology, Charite Universitatsmedizin Berlin, Hohenzollerndamm 2, Berlin, Germany
Int J Antimicrob Agents 32:10-28. 2008..This is also recognised in recent published national and international guidelines, many of which recommend ampicillin/sulbactam as first-line therapy for various respiratory and skin infections...
Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. IntroductionH Lode
Research Center for Medical Studies, Institute for Clinical Pharmacology and Toxicology, , Berlin, Germany
Clin Microbiol Infect 14:1-2. 2008
A prediction model for bacterial etiology in acute exacerbations of COPDH Lode
HELIOS Klinikum Emil von Behring, affiliated Free University Berlin, Chest Hospital Heckeshorn Infectious Disease and Immunology, Zum Heckeshorn 33, 14109, Berlin, Germany
Infection 35:143-9. 2007..We developed a prediction model for infection with gram-negative enteric bacteria (GNEB) and Pseudomonas aeruginosa...
Managing community-acquired pneumonia: a European perspectiveHartmut M Lode
Research Center for Medical Studies RCMS, Institute for Clinical Pharmacology, Charite Universitatsmedizin Berlin, Hohenzollerndamm 2, Ecke Bundesallee, D 10717 Berlin Wilmersdorf, Germany
Respir Med 101:1864-73. 2007..The emergence and spread of resistance to commonly used antibiotics has challenged the management of CAP. Multiple sets of CAP guidelines have been published to address the continued changes in this complex disease...
[Uses in in ambulatory and stationary situations. Clinical indications for beta lactams]Hartmut M Lode
Research Center for Medical Studies, ,
Pharm Unserer Zeit 35:428-31. 2006
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficHartmut Lode
Department of Chest and Infectious Diseases, Hospital Heckeshorn, Akademisches Lehrkrankenhaus, Free University Berlin, Berlin, Germany
Clin Ther 24:1915-36. 2002....
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia]H Grysczyk
Abteilung für Pneumologie und Infektiologie, Lungenklinik Heckeshorn, Zentralklinik Emil von Behrin, Germany
Dtsch Med Wochenschr 127:492-6. 2002..Pulmonary aspergillomas are associated with a high morbidity and mortality. There are only very few data about non-surgical treatment in immunocompetent patients...
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial speciesH F Geerdes-Fenge
Department of Pulmonary and Infectious Diseases, Freie Universitat Berlin, 14109 Berlin, Germany
Antimicrob Agents Chemother 44:3478-80. 2000....
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infectionsH Lode
Pneumologie I Infektiologie and Immunologie, Lungenklinik Heckeshorn, Zum Heckeshorn 33, 14109 Berlin, Germany
Int J Antimicrob Agents 18:199-209. 2001....
Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpointH Lode
Department of Chest and Infectious Diseases, Emil von Behring Hospital, Berlin, Germany
Chemotherapy 47:24-31; discussion 44-8. 2001..Moxifloxacin is currently under observation concerning QTc effects. Levofloxacin has no QTc prolongation and a very low phototoxic potential, making it one of the safest new fluoroquinolones...
In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytesS U Ziege
Department of Chest and Infectious Diseases, City Hospital Zehlendorf Heckeshorn, Berlin, Germany
Eur J Med Res 5:369-74. 2000..66. 9 +/- 14.2%, p = 0.0019). In contrast to prednisolone, neither MON nor PMN chemotaxis was suppressed by IL-10. In conclusion, IL-10 had only marginal immunosuppressive effects on the unspecific immunity compared to prednisolone...
Role of newer fluoroquinolones in lower respiratory tract infectionsH Lode
Department of Chest and Infectious Diseases, Chest Hospital Heckeshorn, Central Clinic Emil von Behring, Zum Heckeshorn 33, 14109 Berlin, Germany
J Antimicrob Chemother 49:709-12. 2002
[Infections caused by Stenotrophomonas maltophilia (SMA) in intensive care patients--a prospective case-control study]M Raffenberg
Lungenklinik Heckeshorn, Zentralklinik Emil von Behring, Akademisches Lehrkrankenhaus der Freien Universität Berlin
Dtsch Med Wochenschr 126:514-8. 2001..The importance of Stenotrophomonas maltophilia (SMA) as an etiologic frequently polyresistant pathogen in severe nosocomial infections has increased...
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faecesOlaf Burkhardt
Department of Chest and Infectious Diseases, Hospital Heckeshorn, Berlin, Germany
Scand J Infect Dis 34:898-903. 2002..8. Pharmacokinetic parameters of clarithromycin and its metabolite, 14-hydroxy-clarithromycin, were similar to previously published data. Accumulation was found. No serious adverse events were observed with either study drug...
Treatment of pneumonia in elderly patientsMalina Schmidt-Ioanas
HELIOS Klinikum Emil von Behring, Department of Chest and Infectious Diseases, Lungenklinik HeckeshornZum Heckeshorn, 3314109 Berlin, Germany
Expert Opin Pharmacother 7:499-507. 2006..Antimicrobial therapy should take into account the most recent guidelines, which are briefly presented in this review. A special consideration should be given to the preventive measures, including vaccination, oral care and nutrition...
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patientMalina Schmidt-Ioanas
HELIOS Klinikum Emil von Behring, Berlin, Germany
Curr Opin Crit Care 11:481-6. 2005..No dramatic superiority of the new drugs in comparison to the standard therapies was observed in most of the clinical trials. Better results on the efficacy of the drugs under investigation are expected...
Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infectionOlaf Burkhardt
Department of Chest and Infectious Diseases, Hospital Heckeshorn, Berlin, Germany
Scand J Infect Dis 35:516-8. 2003..The appearance and circumstances of this nail disorder were consistent with the diagnosis of Beau's lines...
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized studyMathias W R Pletz
Department of Chest and Infectious Diseases, City Hospital Emil von Behring Chest Hospital Heckeshorn, Germany
Antimicrob Agents Chemother 48:780-2. 2004..209 and 0.273 log(10) CFU per ml of sputum per day, respectively. According to the data from our study, moxifloxacin exhibits an early bactericidal activity that is comparable to that of isoniazid...
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases]R Erbes
Lungenklinik Heckeshorn, Krankenhaus Zehlendorf, Berlin
Pneumologie 50:706-11. 1996..MRSA-infection in pulmonary medicine emerged as a problem mostly in patients with multimorbidity and severe underlying diseases. Change of resistance in strains and new strains were observed...
Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokinesMalina Schmidt-Ioanas
Department of Chest and Infectious Diseases, HELIOS Klinikum Emil von Behring, Zum Heckeshorn 33, 14109 Berlin, Germany
Respir Med 100:639-47. 2006..No relationship could be found between the reduced percentage of apoptotic neutrophils in blood and serum concentration of IL-6, IL-8 and TNF-alpha or other clinical parameters in patients with COPD exacerbation...
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteersOlaf Burkhardt
Department of Chest and Infectious Diseases, Chest Hospital Heckeshorn, , Zum Heckeshorn 33, D-14109 Berlin, Germany
J Antimicrob Chemother 50:707-12. 2002..01). Pharmacokinetic parameters of amoxicillin and clavulanic acid found in this study were similar to previously published data. No accumulation was found with co-amoxiclav. No serious adverse event was observed with the study drugs...
Synergistic effects of dexamethasone and quinolones on human-derived tendon cellsJudith Sendzik
Institute of Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Garystr 5, 14195 Berlin, Germany
Int J Antimicrob Agents 35:366-74. 2010..The clinical observations of an increased risk of quinolone-induced tendinopathy by glucocorticoids are supported by these in vitro data...
The impersonatorHartmut Lode
, Berlin, Germany
Am J Med 120:239-41. 2007
Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosisOlaf Burkhardt
Department of Chest and Infectious Diseases, Chest Hospital Heckeshorn, Berlin, Germany
Micron 38:572-9. 2007..Numerous electron-dense inclusions in type III also indicate an increased macrophage activity that leads to an increased release of cytokines, which in turn can trigger an inflammatory reaction...
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive careR Erbes
HELIOS Klinikum Emil von Behring, Zum Heckeshorn 33, D 14109 Berlin, Germany
Eur Respir J 27:1223-8. 2006..These data indicate a high mortality of patients with tuberculosis requiring intensive care unit care and identifies new independently associated risk factors...
Effect of calcium carbonate on bioavailability of orally administered gemifloxacinM W Pletz
Department of Chest and Infectious Diseases, City Hospital E v Behring, Free University of Berlin, Germany
Antimicrob Agents Chemother 47:2158-60. 2003..33 h; and area under the concentration-time curve from 0 h to infinity (AUC( infinity )), 6.79 microg. h/ml. Only simultaneous coadministration of calcium carbonate reduced C(max) (-17%) and AUC( infinity ) (-21%) significantly...
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscessS R Ott
Helios Chest Hospital Heckeshorn, Department of Chest and Infectious Diseases, Affiliated to Charité, University of Medicine Berlin, Walterhöfer Str 11, D 14165, Berlin, Germany
Infection 36:23-30. 2008..An antibiotic therapy, also covering anaerobic pathogens, is the treatment of choice. In this study we compared moxifloxacin (MXF) and ampicillin/sulbactam (AMP/SUL) concerning efficacy and safety in the treatment of AP and PLA...
Safety considerations of fluoroquinolones in the elderly: an updateRalf Stahlmann
Institute of Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany
Drugs Aging 27:193-209. 2010..Because of physiological changes in renal function and when certain co-morbidities are present, some special considerations are necessary when elderly patients are treated with these drugs...
What drives our choices? Evidence, guidelines or habit?Hartmut Lode
Institute for Clinical Pharmacology, Charite Universitatsmedizin Berlin, Germany
Int J Antimicrob Agents 29:S17-22. 2007..Additional factors that should also influence this decision are physicians' prior experience and the individual patient's circumstances...
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administrationDagmar Mainz
Department of Chest and Infectious Diseases, Hospital Heckeshorn-Zehlendorf, Berlin, Germany
J Antimicrob Chemother 50:699-706. 2002..These effects were not so pronounced as to have any therapeutic influence, making dosage adjustment unnecessary...
Fluoroquinolones in the elderly: safety considerationsRalf Stahlmann
Institute of Clinical Pharmacology and Toxicology, Benjamin Franklin Medical Center, Freie Universitat Berlin, Berlin, Germany
Drugs Aging 20:289-302. 2003..Because of physiological changes in renal function and in case of certain comorbidities, some special considerations are necessary when fluoroquinolones are used to treat elderly patients...
[Inpatient treatment costs of exacerbated chronic obstructive lung disease]K Riecke
Abteilung fur Pneumologie, Infektiologie und Immunologie, Lungenklinik Heckeshorn, Berlin
Pneumologie 53:199-206. 1999..The proportion of the pharmacy expenditures was rather small, and hence this is not a primary target for the realisation of major savings...
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microfloraH Lode
Hospital Heckeshorn, , Germany
Scand J Infect Dis 33:899-903. 2001..The administration of linezolid mainly had an impact on the gram-positive bacteria and linezolid thus had an ecological profile different from that of amoxicillin/clavulanic acid...
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteersA Lubasch
Department of Chest and Infectious Diseases, Chest Hospital Heckeshorn, Free University of Berlin, Berlin, Germany
Antimicrob Agents Chemother 44:2600-3. 2000..The five recently developed fluoroquinolones (gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin) showed greater bioavailability, longer half-lives, and higher C(max)s than ciprofloxacin...
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteersA Lubasch
Zentralklinik Emil v. Behring, Lungenklinik Heckeshorn, Department of Chest and Infectious Diseases, Berlin, Germany
Clin Microbiol Infect 9:670-7. 2003..However, for P. aeruginosa, the bactericidal activity of cepefime alone was higher than that of the combination with trovafloxacin...
Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisoloneU K Buchwald
Department of Chest and Infectious Diseases, City Hospital Heckeshorn Zehlendorf, Zum Heckeshorn 33, D 14109 Berlin, Germany
Eur J Med Res 4:85-94. 1999..Our study indicates that IL-10 can behave as a de-activator as well as an activator on the non-specific immune system, depending on the cell type and the concentration...
Improving care for patients with respiratory tract infectionsH Lode
Zentralklinik Emil von Behring, Lungenklinik Heckeshorn, Akademisches Lehrkrankenhaus der FU Berlin, Germany
J Chemother 14:22-8. 2002..Accordingly, this paper focuses on the clinical trial data currently available...
Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitisAnnette Lubasch
Zentralklinik Emil v. Behring, Department Lungenklinik Heckeshorn, Pneumologie I, , Zum Heckeshorn 33, D-14109 Berlin
J Antimicrob Chemother 51:659-64. 2003....
[Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae]M Schmidt-Ioanas
Pneumologische Abteilung I, HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn
Dtsch Med Wochenschr 131:613-7. 2006..The study aimed to determine if a single serological test within the first days of hospital admission may be relevant for the diagnosis of community-acquired pneumonia (CAP) caused by M. pneumoniae...
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscessM Allewelt
Chest Hospital Heckeshorn, affiliated to Free University of Berlin, Berlin, Germany
Clin Microbiol Infect 10:163-70. 2004..Ampicillin + sulbactam and clindamycin +/- cephalosporin were both well-tolerated and proved equally effective in the treatment of aspiration pneumonia and lung abscess...
Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteersM Eisenblatter
Institute for Microbiology and Hygiene, Charite University Medicine Berlin, Campus Benjamin Franklin, Free University and Humboldt University Berlin, Berlin, Germany
Eur J Clin Microbiol Infect Dis 27:1087-92. 2008..Temporal differential effects of azithromycin and clarithromycin on the induction of resistance were observed and need to be investigated regarding their effect on co-colonizing pathogens...
ABT-773: pharmacokinetics and interactions with ranitidine and sucralfateM W Pletz
Department of Chest and Infectious Diseases, E. von Behring City Hospital, Free University of Berlin, Germany
Antimicrob Agents Chemother 47:1129-31. 2003..h/ml. Coadministration of ranitidine, reduced the C(max) (-25.7%) and AUC(0- infinity ) (-15.8%) significantly. Sucralfate had no impact on the bioavailability of ABT-773...
Determination of trovafloxacin in human body fluids by high-performance liquid chromatographyK Borner
Institute for Clinical Chemistry and Pathobiochemistry, , , Germany
J Chromatogr A 846:175-80. 1999..Trovafloxacin was sufficiently separated from endogenous compounds. Results of validation are given. The method was applied successfully to a study of healthy volunteers...
Electron microscopic findings in BAL of a fire-eater after petroleum aspirationOlaf Burkhardt
Department of Chest and Infectious Diseases, Hospital Heckeshorn, Berlin, Germany
Chest 124:398-400. 2003..Despite a large and necrotizing infiltration of the right lower lobe, the clinical course was uneventful with complete recovery...
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical dataJudith Sendzik
Institut fur Klinische Pharmakologie und Toxikologie, Campus Benjamin Franklin, Charite Universitatsmedizin Berlin, Berlin, Germany
Int J Antimicrob Agents 33:194-200. 2009..complicated urinary tract infections and enteritis caused by invasive multidrug-resistant pathogens (e.g. Salmonella, Shigella)...
Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion productionT Schaberg
Department of Pulmonary Medicine, City Hospital Berlin Zehlendorf, Germany
Am Rev Respir Dis 146:1287-93. 1992..The increased binding of smoker AM to endothelial cells could be inhibited by treating the HUVEC with a mAB against ICAM-1. The mAB anti-CD18 reduced O2- release from smoker AM by 42 +/- 5% after 120 min.(ABSTRACT TRUNCATED AT 250 WORDS)..
[Diagnosis and therapy of abscess forming pneumonia]M Allewelt
Zentralklinik Emil von Behring, Department Lungenklinik Heckeshorn, ,
Ther Umsch 58:599-603. 2001..g. recurrent severe hemoptysis, empyema or broncho-pleural fistula...
[Changes in the spectrum of the causative agents of community-acquired pneumonias (1982-1992)]M Allewelt
Pneumologische Abteilung L, Lungenklinik Heckeshorn, Krankenhaus Zehlendorf, Berlin
Dtsch Med Wochenschr 122:1027-32. 1997..The picture of pneumonia acquired out of hospital is continually changing. Microbial aetiology as well as predisposing factors, course and prognosis of this disease were prospectively analysed over a period of 10 years...
Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cellsT Schaberg
Department of Pulmonary Medicine, Chest Hospital Heckeshorn Zehlendorf, Berlin, Germany
Am Rev Respir Dis 147:1507-13. 1993..Our data indicate that the increased expression of LeuCAM on AM in subjects with SA and IPF seems to be involved in the increased O2- production of these cells in both diseases...
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapyA Lubasch
Dept of Chest and Infectious Diseases, Chest Hospital Heckeshorn, Berlin, Germany
Eur Respir J 17:641-6. 2001..In summary, sparfloxacin proved an effective and safe alternative antituberculosis drug for complicated tuberculosis...
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosisA Polzin
Dept of Chest and Infectious Diseases, City Hospital Emil von Behring, Free University of Berlin, Berlin, Germany
Eur Respir J 21:939-43. 2003....
[Pulmonary melioidosis in a German Southeast Asia tourist]K Riecke
, Immunologie und Laboratoriums-medizin, Lungenklinik Heckeshorn, Berlin
Pneumologie 51:499-502. 1997..CONCLUSION: For travellers and immigrants from Southeast Asia presenting smouldering infiltrations of the upper lobes, one should include Melioidosis in the differential diagnosis...
[Chronic eosinophilic pneumonia]M Voss
Pneumologische Abteilung I, Lungenklinik Heckeshorn, Berlin
Dtsch Med Wochenschr 129:1858-60. 2004..In some cases it may be necessary to continue steroid treatment over long periods, even years, to bring the pulmonary changes of CEP under control...
Determination of linezolid in human serum and urine by high-performance liquid chromatographyK Borner
Institute for Clinical Chemistry and Pathobiochemistry, Benjamin Franklin University Hospital, Free University Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany
Int J Antimicrob Agents 18:253-8. 2001..Comparison of HPLC results with results obtained using a quantitative microbiological assay yielded acceptable agreement both for serum and urine. The method was successfully used in a pharmacokinetic study with human volunteers...
[Complex choices in respiratory tract infections: the search for simple solutions]K Klugman
Research Center for Medical Studies, Institute for Clinical Pharmacology, , Hohenzollerndamm 2, D 10717 Berlin, Allemagne
Med Mal Infect 37:1. 2007
Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroidsA de Roux
Department of Chest and Infectious Diseases, City Hospital Heckeshorn, Free University Berlin, Germany
Respir Med 98:1187-94. 2004..CONCLUSIONS: Systemic steroids did not influence the AB-response. In all groups mean AB-concentration increased significantly after vaccination but an important percentage of subjects of all three groups were non-responders...
[Fever of unknown origin in the 21st century. 2. Non-infectious diseases (autoimmune diseases)]T Schneider
Medizinische Klinik 1 (Gastroenterologie, Infektiologie und Rheumatologie, , Campus Benjamin Franklin, Berlin
Dtsch Med Wochenschr 130:2774-8. 2005
Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patientsA de Roux
Department of Chest and Infectious Diseases, Heckeshorn, Helios Kliniken Emil von Behring, Berlin, Germany
Vaccine 24:1537-42. 2006..Systemic steroids did not influence the antibody response towards the MF59-adjuvanted influenza vaccine. We found that the strains included in the vaccine showed varying long-term immunogenicity...
[Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series]T Blum
Klinik für Pneumologie und Infektiologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring
Dtsch Med Wochenschr 131:1515-20. 2006..We report on cases of Pneumocystis jiroveci pneumonia (PcP) (n = 1921) without associated AIDS in a chest hospital...
